Upamostat

upamostat · RedHill Biopharma Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Upamostat, covering 2024-06-06 to 2024-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease [Phase 2, Phase 3]